Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Pfizer Inc Transaction History

Mitsubishi Ufj Kokusai Asset Management Co., Ltd.

$71.7 Billion
Q1 2024

A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Pfizer Inc stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 6,784,970 shares of PFE stock, worth $190 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

6,784,970

Previous 5,617,918 20.77%

Holding current value

$190 Million

Previous $162 Million 16.41%

% of portfolio

0.26%

Previous 0.28%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$25.89 - $29.73 $30.2 Million - $34.7 Million	1,167,052 Added 20.77%	6,784,970 $188 Million
Q4 2023 Feb 08, 2024	BUY	$26.13 - $33.94 $9.51 Million - $12.4 Million	363,931 Added 6.93%	5,617,918 $162 Million
Q3 2023 Nov 07, 2023	BUY	$32.09 - $37.51 $13 Million - $15.2 Million	405,581 Added 8.37%	5,253,987 $174 Million
Q2 2023 Aug 09, 2023	BUY	$36.12 - $41.79 $13.6 Million - $15.8 Million	376,893 Added 8.43%	4,848,406 $178 Million
Q1 2023 May 08, 2023	BUY	$39.39 - $51.28 $17.1 Million - $22.2 Million	433,816 Added 10.74%	4,471,513 $182 Million

Q4 2022 Feb 07, 2023	BUY	$41.75 - $54.5 $19.1 Million - $25 Million	458,280 Added 12.8%	4,037,697 $207 Million
Q3 2022 Nov 01, 2022	BUY	$43.76 - $53.42 $15 Million - $18.3 Million	342,948 Added 10.6%	3,579,417 $157 Million
Q2 2022 Aug 04, 2022	BUY	$46.53 - $55.17 $13.3 Million - $15.8 Million	285,521 Added 9.68%	3,236,469 $170 Million
Q1 2022 May 09, 2022	BUY	$45.75 - $56.69 $11.7 Million - $14.5 Million	256,041 Added 9.5%	2,950,948 $153 Million
Q4 2021 Feb 07, 2022	BUY	$41.32 - $61.25 $15.4 Million - $22.9 Million	373,546 Added 16.09%	2,694,907 $153 Million
Q3 2021 Nov 04, 2021	BUY	$39.25 - $50.42 $8.91 Million - $11.4 Million	226,954 Added 10.84%	2,321,361 $99.8 Million
Q2 2021 Aug 06, 2021	BUY	$35.91 - $40.68 $8.28 Million - $9.38 Million	230,625 Added 12.37%	2,094,407 $82 Million
Q1 2021 May 06, 2021	BUY	$33.49 - $37.77 $6.96 Million - $7.85 Million	207,739 Added 12.54%	1,863,782 $67.5 Million
Q4 2020 Feb 09, 2021	BUY	$33.47 - $42.56 $2.35 Million - $2.99 Million	70,307 Added 4.43%	1,656,043 $61 Million
Q3 2020 Nov 10, 2020	BUY	$31.75 - $37.25 $5.04 Million - $5.91 Million	158,706 Added 11.12%	1,585,736 $58.2 Million
Q2 2020 Aug 06, 2020	BUY	$30.12 - $36.54 $7.09 Million - $8.61 Million	235,557 Added 19.77%	1,427,030 $46.7 Million
Q1 2020 May 11, 2020	BUY	$27.03 - $38.62 $776,463 - $1.11 Million	28,726 Added 2.47%	1,191,473 $38.9 Million
Q4 2019 Feb 05, 2020	BUY	$32.92 - $37.36 $4.25 Million - $4.82 Million	129,080 Added 12.49%	1,162,747 $45.3 Million
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $1.26 Million - $1.64 Million	38,925 Added 3.91%	1,033,667 $37.1 Million
Q2 2019 Aug 08, 2019	BUY	$36.98 - $41.52 $5.88 Million - $6.61 Million	159,104 Added 19.04%	994,742 $43.1 Million
Q1 2019 Apr 26, 2019	BUY	$37.5 - $41.2 $1.53 Million - $1.68 Million	40,747 Added 5.13%	835,638 $35.5 Million
Q4 2018 Feb 08, 2019	SELL	$38.47 - $43.86 $1.88 Million - $2.15 Million	-48,977 Reduced 5.8%	794,891 $33.4 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $884,052 - $1.07 Million	-25,647 Reduced 2.95%	843,868 $37.2 Million
Q2 2018 Aug 09, 2018	SELL	$32.98 - $35.16 $150,982 - $160,962	-4,578 Reduced 0.52%	869,515 $31.5 Million
Q1 2018 May 02, 2018	SELL	$31.91 - $37.02 $2.25 Million - $2.62 Million	-70,650 Reduced 7.48%	874,093 $31 Million
Q4 2017 Feb 06, 2018	BUY	$33.26 - $35.29 $518,889 - $550,559	15,601 Added 1.68%	944,743 $34.7 Million
Q3 2017 Nov 01, 2017	BUY	$31.0 - $34.15 $28.8 Million - $31.7 Million	929,142	929,142 $33.2 Million

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.

Account

Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Pfizer Inc Transaction History